Merck KGaA (ETR:MRK) Shares Down 0.3% – What’s Next?

Shares of Merck KGaA (ETR:MRKGet Free Report) were down 0.3% on Tuesday . The stock traded as low as €153.35 ($168.52) and last traded at €153.60 ($168.79). Approximately 148,117 shares were traded during trading, The stock had previously closed at €154.05 ($169.29).

Merck KGaA Stock Down 0.3 %

The company has a quick ratio of 0.72, a current ratio of 1.31 and a debt-to-equity ratio of 37.56. The firm has a 50 day moving average of €161.79 and a two-hundred day moving average of €161.32. The firm has a market capitalization of $19.85 billion, a price-to-earnings ratio of 25.43, a price-to-earnings-growth ratio of 2.37 and a beta of 0.71.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

See Also

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.